The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2016 | Quality over quantity – a look at the ASH and ASCO social media networks
Michael Thompson, MD, PhD of the Aurora Health Care, Milwaukee, WI talks about the quality of the ASCO and ASH conference social media networks and how this might make them valuable to medical professionals. Dr Thompson discusses the quality of the ASCO and ASH networks in terms of 9 metrics such as connectivity and diversity and how they are expanding. Apart from Twitter, he also mentions the use of Snapchat, Periscope and Instagram.
Recorded at the American Society of Oncology (ASCO) 2016 Annual Meeting held in Chicago, IL.
